The research has revealed eleven new genetic regions
associated with the blood levels of the metabolites, including new loci
affecting well-established risk markers for cardiovascular disease and
potential biomarkers for type 2 diabetes.
In
a study to the genetic variance of human metabolism, specialists have
identified thirty one regions of the genome that were related with levels of
circulating metabolites, i.e., small molecules that take part in different
chemical reactions of human body. Many of the studied metabolites are
biomarkers for cardiovascular disease or related disorders, accordingly the
loci uncovered may provide valuable insight into the biological processes
leading to common diseases.
Lab
tests used in the clinic typically monitor one or few circulating metabolites.
The researchers used a high throughput method called nuclear magnetic resonance
that can measure more than hundred different metabolites in one assay. This
provides a considerably more in-depth picture of circulating metabolic
compounds.
The
group assayed 117 detailed metabolic markers, including amino acids, lipids and
lipoprotein subclasses, and conducted the largest genome-wide association
analysis of this type, in terms of study sample size of 8330 individuals and
7.7 million genomic markers studied. They revealed, in total, 31 genetic
regions related with the blood levels of the metabolites.
Among
the discoveries were two new loci influencing serum cholesterol subclass
measures, well-established risk markers for cardiovascular disease, and five
new loci affecting levels of amino acids recently discovered to be potential biomarkers for type 2 diabetes. The found variants have significant
effects on the metabolite levels, the effect sizes being in general
considerably larger than the known common variants for complex disease have.
Additionally,
using twin pair samples, the scientists indicated that the metabolite levels
show a high degree of heritability. This result suggests that the studied
metabolites are describing better the underlying biology than the routinely
used lab tests. In this way, the examination provides further support for the
use of detailed data on multitude of metabolites in genetic studies to provide
novel biological insights and to help in elucidating the processes leading to
common diseases.
Contact details:
Tiffany Hales
Program Manager | Diabetic 2018
Mail id: diabetes@mehealthevents.org
Tiffany Hales
Program Manager | Diabetic 2018
Mail id: diabetes@mehealthevents.org